Illumina

Overview of Illumina Technology:

Sampled has partnered with Illumina, a leader in genomic technology for our sequencing and array assays. Illumina has been at the cutting edge of high throughput genomics since 1998 and continues to innovate within both the research and clinical space.

With this technology, Sampled is able to provide:

• High throughput Sequencing
• Microarray Analysis
• Whole Genome Sequencing
• Metagenomics
• Epigenetics
• Bioinformatic Analysis

---

Illumina technology at Sampled:

Whole Genome Sequencing (WGS)

• Perform WGS on both clinical and research samples.
• Clinical samples have the option to run on a clinically validated assay in Sampled’s CLIA certified lab.
• Receive bioinformatic analysis using the award-winning DRAGEN pipeline.

Whole Exome Sequencing (WES)

• Similar to WGS, your WES samples can be run in either research setting or with a clinically validated assay in Sampled’s CLIA certified lab.
• Receive bioinformatic analysis using the DRAGEN pipeline.

Methylation Analysis

• Sampled makes data analysis as simple as possible for users. We offer data analysis from our established SeSAMe pipeline that provides differential methylation analysis, epigenetic age, Copy Number Variation, ethnicity determination, and high quality QC.
• Methylation analysis can be used for Epigenome-Wide Association Studies, Methylation Risk Scores, Methylation Age Clocks, Methylation Cytometry and Immune cell deconvolution.
• Methylation analysis is also an excellent complement to other types of genomics, NGS, and arrays.

Genotyping and Pharmacogenomics

• Illumina offers multiple solutions for genomic disease research, including GWAS, Polygenic Risk Score, Clinical Trial design and sample stratification. This technology has options to fit your needs with offerings across different throughput and coverage levels from thousands to millions of variants assays per sample.
• Illumina’s Global Diversity Array with Enhanced Pharmacogenomics offers comprehensive and updated coverage of PGx variants across CPIC and PharmGKB level as well as high accuracy CNV and star allele calling for key genes, including CYP2D6. Sampled also offers clinical PGx reporting for drug-gene and drug-drug-gene interactions.

Also Available Using This Technology:

• Clinically Validated Hereditary Cancer Testing
• Pre-conception Carrier Screening
• Noninvasive Pre-natal Testing
• Microbiology

---

Platforms Overview: